Evonik and BellaSeno advance commercialization of
Expanded partnership of two leading innovatorsResomer® used in commercial 3D-printed implants for both soft and hard
Globe Newswire6-03-2023, 16:18
Junshi Biosciences Announces Initiation of Phase 3 Study of Tifcemalimab plus Toripalimab for Treatment of Limited-stage Small Cell Lung Cancer 29-06-2023, 12:59